Multicenter Registry of Atrial Fibrillation Ablation With Radiofrequency Balloon Catheter
Recruiting
Observational Study
Atrial Fibrillation
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- Universitair Ziekenhuis Brussel · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
All consecutive patients with paroxysmal or persistent atrial fibrillation undergoing pulmonary vein isolation with the radiofrequency balloon catheter (RFB) "Heliostar" (Biosense Webster) will be included in a multicenter observational registry. The aim of the study is to assess the safety and arrhythmic outcome of atrial fibrillation ablation with the RFB in a real-world setting.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* symptomatic atrial fibrillation with indication to catheter ablation
Exclusion Criteria:
* age \<18 years old
* pregnancy
* any contraindications to catheter ablation
Contacts